Imugene's Phase 1b Azer-cel trial 57% complete response rate

By Proactive Investors / February 14, 2025 / www.youtube.com / Article Link


Imugene Ltd (ASX: IMU, OTC: IUGNF) chief medical officer Dr. Paul Woodard and managing director and CEO Leslie Chong ...

Recent News

Gold stocks outperform equities surge

May 11, 2026 / www.canadianminingreport.com

Global tech once again leading the markets in 2026

May 11, 2026 / www.canadianminingreport.com

Gold stocks decline as equities reach all-time highs

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok